RBC Capital Maintains Outperform on Stericycle, Raises Price Target to $69
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Sean Dodge maintains an Outperform rating on Stericycle (NASDAQ:SRCL) and raises the price target from $58 to $69.
February 29, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital analyst Sean Dodge maintains an Outperform rating on Stericycle and raises the price target from $58 to $69.
The upgrade in price target by a reputable analyst like Sean Dodge from RBC Capital is a strong positive signal for Stericycle. It suggests confidence in the company's future performance and growth potential, likely leading to increased investor interest and potentially a rise in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100